Cookie policy notice

By continuing to use this site you agree to our cookies policy below:
Since 26 May 2011, the law now states that cookies on websites can ony be used with your specific consent. Cookies allow us to ensure that you enjoy the best browsing experience.

This site is intended for health professionals only

At the heart of general practice since 1960

GPs on the stock market, cannabis and psychosis, a new test for prostate cancer and the Mozart effect

Our roundup of the health news headlines on Wednesday 2 March.

By Alisdair Stirling

Our roundup of the health news headlines on Wednesday 2 March.

GP practices could be partially floated on the stock market, a report in today's Guardian suggests.

Documents obtained by Channel 4 News and passed to the Guardian, show a private health firm, IHP, proposes that the commissioning budget for patients be handed over to a private company in which GPs would own a 20% stake.

IHP is in talks with three GP consortiums to set up a company that would turn underspends in their annual budget – in effect, savings on patient spending – into profits.

This company, which aims to list on the stock market in three to five years, would treat patients at 95% of the cost of the NHS. This putative saving, amounting to £40 per patient, would be booked as 'profit'.

Elsewhere, smoking cannabis doubles the risk of psychosis for teenagers, according to the Daily Mail, reporting on a new study in the BMJ. Young people who started smoking the drug at college were 90% more likely to have psychotic symptoms in their mid-20s, the study of 1,900 14 to 24-year old Germans found.

And some users suffered psychotic symptoms including hallucinations, delusions and disordered thoughts. The research team - from Germany, the Netherlands and the Institute of Psychiatry in London - concluded: ‘Cannabis use precedes the onset of psychotic symptoms in individuals with no history of them.'

The Mail also reports that a reliable test for prostate cancer could be available within months.

The new test measures production of a protein called EN2, and initial studies show it to be much more accurate than previous tests. In trials on 288 men it detected up to 70% of cancers, making it roughly twice as good as the PSA test.

Importantly, it gave false positive results just 4% of the time – ten times less often than the PSA test, according to a study in Clinical Cancer Research.

The Daily Telegraph also covers the story reported in Pulse with a different spin - that 100,0000 patients in England have received the wrong diabetes diagnosis.

For every 500 people identified with diabetes on a GP register, about 65 to 70 could need to be looked at again for some sort of error, the paper says.

Finally, the health effects of music - the so-called 'Mozart effect' - are reported in the Daily Express.

Scientists believe music can soothe pain, make you fitter, benefit epilepsy sufferers and speed recovery after a stroke, according to the Mail.

After suffering years of chronic pain patients who listened to music for just one hour a day for a week reported a cut in pain levels of up to 21% and in associated depression of up to 25%, a study published in the Journal of Advanced Nursing showed.

Spotted a story we've missed? Let us know in the comments and we'll update the digest throughout the day...

Daily digest

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say